Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Top Cited Papers
- 10 February 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Virchows Archiv
- Vol. 460 (3), 237-249
- https://doi.org/10.1007/s00428-012-1203-5
Abstract
Malignant epithelial tumors (carcinomas) are the most common ovarian cancers and also the most lethal gynecological malignancies. Based on histopathology and molecular genetic alterations, ovarian carcinomas are divided into five main types (high-grade serous (70%), endometrioid (10%), clear cell (10%), mucinous (3%), and low-grade serous carcinomas (<5%)) that account for over 95% of cases. These types are essentially distinct diseases, as indicated by differences in epidemiological and genetic risk factors, precursor lesions, patterns of spread, and molecular events during oncogenesis, response to chemotherapy, and prognosis. For a successful specific treatment, reproducible histopathological diagnosis of the tumor cell type is critical. The five tumor types are morphologically diverse and resemble carcinomas of the uterus. Actually, recent investigations have demonstrated that a significant number of cancers, traditionally thought to be primary ovarian tumors (particularly serous, endometrioid, and clear cell carcinomas), originate in the fallopian tube and the endometrium and involve the ovary secondarily. This review summarizes recent advances in the molecular pathology which have greatly improved our understanding of the biology of ovarian carcinoma and are also relevant to patient management.Keywords
This publication has 85 references indexed in Scilit:
- Low‐grade serous carcinomas of the ovary contain very few point mutationsThe Journal of Pathology, 2011
- Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomasGynecologic Oncology, 2011
- The molecular pathogenesis of hereditary ovarian carcinomaCancer, 2010
- ARID1AMutations in Endometriosis-Associated Ovarian CarcinomasThe New England Journal of Medicine, 2010
- The genesis and evolution of high-grade serous ovarian cancerNature Reviews Cancer, 2010
- Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesisOncogene, 2009
- Defining the Cut Point Between Low-grade and High-grade Ovarian Serous CarcinomasThe American Journal of Surgical Pathology, 2009
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutationsGynecologic Oncology, 2008
- Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical stagingBritish Journal of Cancer, 2006
- Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancerThe Journal of Pathology, 2001